These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
139 related items for PubMed ID: 558266
21. Urinary cross-linked fibrin degradation products in glomerular disease with crescents. Kamitsuji H, Matsunaga K, Taira K, Nakajima M, Whitworth JA, Kincaid-Smith P. Clin Nephrol; 1988 Mar; 29(3):124-8. PubMed ID: 3359703 [Abstract] [Full Text] [Related]
22. Immunoreactivities of fibrin(ogen) related antigens and antibodies in radioimmunoassay and latex photometric immunoassay. Sudo T, Sawai M. Nihon Ketsueki Gakkai Zasshi; 1981 Feb; 44(1):131-45. PubMed ID: 7315137 [No Abstract] [Full Text] [Related]
24. Plasma cross-linked fibrin degradation product (XLFbDP) assays in an in vivo model of fibrinolysis. Rowbotham BJ, Whitaker AN, Masci PP. Blood Coagul Fibrinolysis; 1990 Dec; 1(6):653-61. PubMed ID: 2133245 [Abstract] [Full Text] [Related]
30. Deposition of fibrin-stabilizing factor (F XIIIA and S), fibrinogen-related antigens, fibrinogen degradation products (FDPd and FDPe) and antihemolytic factor (F VIII) in renal disease: analysis of 161 cases by immunofluorescence microscopy. Colasanti G, Morel Maroger L, D'Amico G. Clin Nephrol; 1987 Jul; 28(1):28-34. PubMed ID: 3113791 [Abstract] [Full Text] [Related]
31. Heparin therapy in anti-basement membrane nephritis. Bone JM, Valdes AJ, Germuth FG, Lubowitz H. Kidney Int; 1975 Aug; 8(2):72-9. PubMed ID: 1160229 [Abstract] [Full Text] [Related]
32. Lymphocyte suppressive peptides from fibrinogen are derived predominantly from the A alpha chain. Plow EF, Edgington TS. J Immunol; 1986 Sep 15; 137(6):1910-5. PubMed ID: 2943807 [Abstract] [Full Text] [Related]
33. [Clinical significance of a new fibrinogen/fibrin degradation products(FDP) test using plasma samples for the diagnosis of fibrinogenolysis and fibrinolysis]. Imoto K, Yasumuro Y, Taki M, Suzuki N, Tanabe H, Ichikawa Y. Rinsho Byori; 2001 Mar 15; 49(3):283-9. PubMed ID: 11307330 [Abstract] [Full Text] [Related]
34. [Clinical significance of urinary fibrin/fibrinogen degradation products in renal disease. First report: Urinary fibrin/fibrinogen degradation products in primary glomerulonephritis (author's transl)]. Miyamura S. Nihon Jinzo Gakkai Shi; 1978 Jan 15; 20(1):67-78. PubMed ID: 650992 [No Abstract] [Full Text] [Related]
36. [The radioimmunological assay of fibrinogen breakdown products with E antigen during postoperative venous thromboses. Study in 46 cases of arthroplasty for osteoarthrosis of the hip (author's transl)]. Dechavanne M, Ville D, Clermont N, Pouillaude JM, Clermont A, Viala JJ, de Mourgues G. Nouv Presse Med; 1977 Nov 26; 6(40):3721-4. PubMed ID: 604924 [Abstract] [Full Text] [Related]
37. Significance of urinary fibrin/fibrinogen degradation products (FDP) D-dimer measured by a highly sensitive ELISA method with a new monoclonal antibody (D-D E72) in various renal diseases. Shibata T, Magari Y, Kamberi P, Ishii T, Tomo T, Yasumori R, Nasu M. Clin Nephrol; 1995 Aug 26; 44(2):91-5. PubMed ID: 8529315 [Abstract] [Full Text] [Related]
38. A diazophenylthio-ether-IgG probe for analysing fibrin- and fibrinogen-related antigens. Kruskal JB, Maeder DL, Purves LR, Franks JJ, Kirsch RE. S Afr Med J; 1987 Feb 21; 71(4):211-7. PubMed ID: 3824087 [Abstract] [Full Text] [Related]
39. Urinary fibrinogen and fibrin fragments in children with renal disease. Yoshioka K, Iseki T, Akano N, Uraoka Y, Miyata H, Maki S. Nephron; 1982 Feb 21; 32(2):135-9. PubMed ID: 7177290 [Abstract] [Full Text] [Related]
40. Urinary fibrin-fibrinogen degradation products (FDP) and glomerulonephritis. Hedner U, Ekberg M, Nilsson IM. Acta Med Scand; 1974 Feb 21; 195(1-2):81-5. PubMed ID: 4817097 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]